The decline in age at puberty in the general population has been paralleled by an increase in the number of girls referred for evaluation of precocious puberty (PP). In 1999, The Lawson Wilkins Pediatric Endocrine Society recommended a lowering of the age limit for evaluation of PP in girls. However, the limited evidence on which these recommendations were based led many experts to question these new suggestions. The emergence of new European pubertal timing data evaluated by robust clinical as well as biochemical markers has broadened our insight on how to interpret the recent pubertal changes. The recent pubertal trends have resulted in a concomitant lowering of the lower limit of normality of the pubertal onset. However, evidence suggests that age at the gonadotropin and sex steroid surges have not changed. Thus, it looks as if an increasing proportion of contemporary early pubertal girls may experience isolated gonadotropin-independent thelarche rather than central PP, which may not be discernible on pubertal examination alone. Thus, the population-based limits of normality should not be directly translated into revision of age limits for evaluation of PP due to the risk of misdiagnosing rapid progressive PP as well as intracranial and other underlying pathology.

Keywords:
Orchidometry, Thelarche, Precocious puberty, Pubertal timing, Pubertal examination
1.
Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, Sharpe RM, Skakkebaek NE, Toppari J: Public health implications of altered puberty timing. Pediatrics 2008;121(suppl 3):S218–S230.
2.
Euling SY, Selevan SG, Pescovitz OH, Skakkebaek NE: Role of environmental factors in the timing of puberty. Pediatrics 2008;121(suppl 3):S167–S171.
3.
Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM: Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505–512.
4.
Herman-Giddens ME, Wang L, Koch G: Secondary sexual characteristics in boys: estimates from the national health and nutrition examination survey III, 1988–1994. Arch Pediatr Adolesc Med 2001;155:1022–1028.
5.
Karpati AM, Rubin CH, Kieszak SM, Marcus M, Troiano RP: Stature and pubertal stage assessment in American boys: the 1988–1994 Third National Health and Nutrition Examination Survey. J Adolesc Health 2002;30:205–212.
6.
Sun SS, Schubert CM, Chumlea WC, Roche AF, Kulin HE, Lee PA, Himes JH, Ryan AS: National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 2002;110:911–919.
7.
Sun SS, Schubert CM, Liang R, Roche AF, Kulin HE, Lee PA, Himes JH, Chumlea WC: Is sexual maturity occurring earlier among U.S. children? J Adolesc Health 2005;37:345–355.
8.
Juul A, Teilmann G, Scheike T, Hertel NT, Holm K, Laursen EM, Main KM, Skakkebaek NE: Pubertal development in Danish children: comparison of recent European and US data. Int J Androl 2006;29:247–255.
9.
Mul D, Fredriks AM, van BS, Oostdijk W, Verloove-Vanhorick SP, Wit JM: Pubertal development in The Netherlands 1965–1997. Pediatr Res 2001;50:479–486.
10.
Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A: Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 2009;123:e932–e939.
11.
Rubin C, Maisonet M, Kieszak S, Monteilh C, Holmes A, Flanders D, Heron J, Golding J, McGeehin M, Marcus M: Timing of maturation and predictors of menarche in girls enrolled in a contemporary British cohort. Paediatr Perinat Epidemiol 2009;23:492–504.
12.
Sorensen K, Aksglaede L, Petersen JH, Juul A: Recent changes in pubertal timing in healthy Danish boys: associations with body mass index. J Clin Endocrinol Metab 2010;95:263–270.
13.
Mogensen SS, Aksglaede L, Mouritsen A, Sorensen K, Main KM, Gideon P, Juul A: Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty. J Clin Endocrinol Metab 2011;96:1393–1401.
14.
Kaplowitz PB, Oberfield SE: Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999;104:936–941.
15.
Chalumeau M, Hadjiathanasiou CG, Ng SM, Cassio A, Mul D, Cisternino M, Partsch CJ, Theodoridis C, Didi M, Cacciari E, Oostdijk W, Borghesi A, Sippell WG, Breart G, Brauner R: Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr 2003;143:445–450.
16.
Midyett LK, Moore WV, Jacobson JD: Are pubertal changes in girls before age 8 benign? Pediatrics 2003;111:47–51.
17.
Rosenfield RL, Bachrach LK, Chernausek SD, Gertner JM, Gottschalk M, Hardin DS, Pescovitz OH, Saenger P: Current age of onset of puberty. Pediatrics 2000;106:622–623.
18.
Viner R: Splitting hairs. Arch Dis Child 2002;86:8–10.
19.
Elks CE, Perry JR, Sulem P, Chasman DI, et al: Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 2010;42:1077–1085.
20.
Kaprio J, Rimpela A, Winter T, Viken RJ, Rimpela M, Rose RJ: Common genetic influences on BMI and age at menarche. Hum Biol 1995;67:739–753.
21.
Kaplowitz PB: Link between body fat and the timing of puberty. Pediatrics 2008;121(suppl 3):S208–S217.
22.
Ong KK, Ahmed ML, Dunger DB: Lessons from large population studies on timing and tempo of puberty (secular trends and relation to body size): the European trend. Mol Cell Endocrinol 2006;254–255:8–12.
23.
Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME: Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 2001;108:347–353.
24.
Wang Y: Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002;110:903–910.
25.
Ribeiro J, Santos P, Duarte J, Mota J: Association between overweight and early sexual maturation in Portuguese boys and girls. Ann Hum Biol 2006;33:55–63.
26.
Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP: The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24:668–693.
27.
Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebaek NE, Juul A: Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010;95:5357–5364.
28.
Chellakooty M, Schmidt IM, Haavisto AM, Boisen KA, Damgaard IN, Mau C, Petersen JH, Juul A, Skakkebaek NE, Main KM: Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab 2003;88:3515–3520.
29.
Hagen CP, Aksglaede L, Sorensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A: Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003–5010.
30.
Hagen CP, Main KM, Kjaergaard S, Juul A: FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Hum Reprod 2010;25:3134–3141.
31.
Palmert MR, Hayden DL, Mansfield MJ, Crigler JF Jr, Crowley WF Jr, Chandler DW, Boepple PA: The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001;86:4536–4542.
32.
Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sorensen TI, Dunkel L, Himes JH, Teilmann G, Swan SH: Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 2008;121(suppl 3):S172–S191.
33.
Zachmann M, Prader A, Kind HP, Hafliger H, Budliger H: Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helv Paediatr Acta 1974;29:61–72.
34.
Slora EJ, Bocian AB, Herman-Giddens ME, Harris DL, Pedlow SE, Dowshen SA, Wasserman RC: Assessing inter-rater reliability (IRR) of Tanner staging and orchidometer use with boys: a study from PROS. J Pediatr Endocrinol Metab 2009;22:291–299.
35.
Tanner JM: Trend towards earlier menarche in London, Olso, Copenhagen, the Netherlands and Hungary. Nature 1973;243:95–96.
36.
Wyshak G, Frisch RE: Evidence for a secular trend in age of menarche. N Engl J Med 1982;306:1033–1035.
37.
Chumlea WC, Schubert CM, Roche AF, Kulin HE, Lee PA, Himes JH, Sun SS: Age at menarche and racial comparisons in US girls. Pediatrics 2003;111:110–113.
38.
Anderson SE, Dallal GE, Must A: Relative weight and race influence average age at menarche: results from two nationally representative surveys of US girls studied 25 years apart. Pediatrics 2003;111:844–850.
39.
Biro FM, Galvez MP, Greenspan LC, Succop PA, Vangeepuram N, Pinney SM, Teitelbaum S, Windham GC, Kushi LH, Wolff MS: Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics 2010;126:e583–e590.
40.
Papadimitriou A, Pantsiotou S, Douros K, Papadimitriou DT, Nicolaidou P, Fretzayas A: Timing of pubertal onset in girls: evidence for non-Gaussian distribution. J Clin Endocrinol Metab 2008;93:4422–4425.
41.
Semiz S, Kurt F, Kurt DT, Zencir M, Sevinc O: Pubertal development of Turkish children. J Pediatr Endocrinol Metab 2008;21:951–961.
42.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.
43.
Biro FM, Lucky AW, Huster GA, Morrison JA: Pubertal staging in boys. J Pediatr 1995;127:100–102.
44.
Foster TA, Voors AW, Webber LS, Frerichs RR, Berenson GS: Anthropometric and maturation measurements of children, ages 5 to 14 years, in a biracial community – the Bogalusa Heart Study. Am J Clin Nutr 1977;30:582–591.
45.
Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE: Secondary sex characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr 1979;95:293–297.
46.
Herman-Giddens ME: Recent data on pubertal milestones in United States children: the secular trend toward earlier development. Int J Androl 2006;29:241–246.
47.
Walvoord EC: The timing of puberty: is it changing? Does it matter? J Adolesc Health 2010; 47:433–439.
48.
Sorensen K, Nielsen J, Busch P, Hamborg-Petersen B, Hansen E, Lassen LB, Nielsen K, Poulsen JP, Rossen K, Schaap SK, Taudorf K, Thelle T, Vestermark S, Vrang C: Measurement of testicular volume with Prader’s orchiometer in 1,389 boys 5–15 1/2 years old. Ugeskr Laeger 1979;141:915–918.
49.
Albertsson-Wikland K, Rosberg S, Lannering B, Dunkel L, Selstam G, Norjavaara E: Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab 1997;82:541–549.
50.
Davison KK, Susman EJ, Birch LL: Percent body fat at age 5 predicts earlier pubertal development among girls at age 9. Pediatrics 2003;111:815–821.
51.
Sorensen K, Aksglaede L, Munch-Andersen T, Aachmann-Andersen NJ, Petersen JH, Hilsted L, Helge JW, Juul A: Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. Diabetes Care 2009;32:909–914.
52.
Buck Louis GM, Gray LE Jr, Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, Sippell W, Abbott DH, Soto A, Tyl RW, Bourguignon JP, Skakkebaek NE, Swan SH, Golub MS, Wabitsch M, Toppari J, Euling SY: Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008;121(suppl 3):S192–S207.
53.
Cisternino M, Arrigo T, Pasquino AM, Tinelli C, Antoniazzi F, Beduschi L, Bindi G, Borrelli P, De S, V, Farello G, Galluzzi F, Gargantini L, Lo PD, Sposito M, Tato L: Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab 2000;13(suppl 1):695–701.
54.
Carel JC, Eugster EA, Rogol A, Ghizzoni L, et al: Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–e762.
55.
Nathan BM, Palmert MR: Regulation and disorders of pubertal timing. Endocrinol Metab Clin North Am 2005;34:617–641, ix.
56.
Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A: Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 2005;116:1323–1328.
57.
Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
58.
Mogensen SS, Aksglaede L, Mouritsen A, Sorensen K, Main KM, Gideon P, Juul A: Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty. PLoS One, DOI:10.1371/journal.pone. 0029829.
59.
Ng SM, Kumar Y, Cody D, Smith CS, Didi M: Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 2003;88:414–418.
60.
Sorensen K, Mouritsen A, Mogensen SS, Aksglaede L, Juul A: Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression. J Clin Endocrinol Metab 2010;95:3736–3744.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.